Open Access

Role of ABCB1 and glutathione S‑transferase gene variants in the association of porphyria cutanea tarda and human immunodeficiency virus infection

  • Authors:
    • Priscila Ayelén Pagnotta
    • Viviana Alicia Melito
    • Jimena Verónica Lavandera
    • Victoria Estela Parera
    • María Victoria Rossetti
    • Johanna Romina Zuccoli
    • Ana Maria Buzaleh
  • View Affiliations

  • Published online on: December 4, 2020     https://doi.org/10.3892/br.2020.1398
  • Article Number: 22
  • Copyright: © Pagnotta et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In Argentina, porphyria cutanea tarda (PCT) is strongly associated with infection with human immunodeficiency virus (HIV); however, whether the onset of this disease is associated with HIV infection and/or the antiretroviral therapy has not been determined. The ABCB1 gene variants c.1236C>T, c.2677G>T/A and c.3435C>T affect drug efflux. The GSTT1 null, GSTM1 null and GSTP1 (c.313A>G) gene variants alter Glutathione S‑transferase (GST) activity, modifying the levels of xenobiotics. The aim of the present study was to evaluate the role of genetic variants in initiation of PCT and to analyze the genetic basis of the PCT‑HIV association. Control individuals, and HIV, PCT and PCT‑HIV patients were recruited, PCR‑restriction fragment length polymorphism was used to genotype the ABCB1 and GSTP1 variants, and multiplex PCR was used to study the GSTM1 and GSTT1 variants. The high frequency of c.3435C>T (PCT and PCT‑HIV) and c.1236C>T (PCT) suggested that the onset of PCT were not specifically related to HIV infection or antiretroviral therapy for these variants. c.2677G>T/A frequencies in the PCT‑HIV patients were higher compared with the other groups, suggesting that a mechanism involving antiretroviral therapy served a role in this association. PCT‑HIV patients also had a high frequency of GSTT1 null and low frequency for GSTM1 null variants; thus, the genetic basis for PCT onset may involve a combination between the absence of GSTT1 and the presence of GSTM1. In conclusion, genes encoding for proteins involved in the flow and metabolism of xenobiotics may influence the PCT‑HIV association. The present study is the first to investigate the possible role of GST and ABCB1 gene variants in the triggering of PCT in HIV‑infected individuals, to the best of our knowledge, and may provide novel insights into the molecular basis of the association between PCT and HIV.
View Figures
View References

Related Articles

Journal Cover

February-2021
Volume 14 Issue 2

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Pagnotta PA, Melito VA, Lavandera JV, Parera VE, Rossetti MV, Zuccoli JR and Buzaleh AM: Role of <em>ABCB1</em> and glutathione S‑transferase gene variants in the association of porphyria cutanea tarda and human immunodeficiency virus infection. Biomed Rep 14: 22, 2021
APA
Pagnotta, P.A., Melito, V.A., Lavandera, J.V., Parera, V.E., Rossetti, M.V., Zuccoli, J.R., & Buzaleh, A.M. (2021). Role of <em>ABCB1</em> and glutathione S‑transferase gene variants in the association of porphyria cutanea tarda and human immunodeficiency virus infection. Biomedical Reports, 14, 22. https://doi.org/10.3892/br.2020.1398
MLA
Pagnotta, P. A., Melito, V. A., Lavandera, J. V., Parera, V. E., Rossetti, M. V., Zuccoli, J. R., Buzaleh, A. M."Role of <em>ABCB1</em> and glutathione S‑transferase gene variants in the association of porphyria cutanea tarda and human immunodeficiency virus infection". Biomedical Reports 14.2 (2021): 22.
Chicago
Pagnotta, P. A., Melito, V. A., Lavandera, J. V., Parera, V. E., Rossetti, M. V., Zuccoli, J. R., Buzaleh, A. M."Role of <em>ABCB1</em> and glutathione S‑transferase gene variants in the association of porphyria cutanea tarda and human immunodeficiency virus infection". Biomedical Reports 14, no. 2 (2021): 22. https://doi.org/10.3892/br.2020.1398